Pfizer launches drug sales platform directly targeting American patients
白云追月素
发表于 2024-8-27 20:28:12
211
0
0
On August 27, PfizerForAll.com, a user friendly platform launched by Pfizer, allows American users to make an appointment for vaccination or have a virtual meeting with doctors, who can prescribe drugs for COVID-19, migraine and other diseases, and then deliver the drugs to patients' homes.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- The number of employees in Starbucks' US stores continues to decline due to the policy of 'adding stores but not adding people'
- Black Friday Quick Report: Online and offline online shopping in the United States is expected to set a new record!
- Pfizer and CR Pharma reach strategic partnership on four mature drugs
- Delaware judge overturns Musk salary agreement, Tesla says it will appeal
- Tesla surged last night! Bank of America raises Tesla's 12-month target price to $400 and maintains buy rating
- Weekly Outlook | US CPI may shake expectations of Fed interest rate cuts! Oracle and Broadcom announce their performance, will it affect the subsequent trend of AI concept stocks?
- Pfizer expects revenue of $61 billion to $64 billion in 2025, with an estimated $63.23 billion
- The US warehouse strike poses challenges to Amazon's holiday shopping season operations
- Eli Lilly's new Alzheimer's disease drug launched: annual drug cost exceeds $30000, Pfizer Roche is expanding its strategy
- Jianxun Daily | Hengrui Pharmaceutical and IDEAYA signed an authorization agreement; Liu Zhongliang, the actual controller of Weikang Pharmaceutical, has been registered
